Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 5.44 USD -0.91%
Market Cap: 415.5m USD
Have any thoughts about
Chromadex Corp?
Write Note

Chromadex Corp
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Chromadex Corp
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Chromadex Corp
NASDAQ:CDXC
Long-Term Debt
$2k
CAGR 3-Years
-42%
CAGR 5-Years
-51%
CAGR 10-Years
-42%
Thermo Fisher Scientific Inc
NYSE:TMO
Long-Term Debt
$31.2B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
11%
Danaher Corp
NYSE:DHR
Long-Term Debt
$16.3B
CAGR 3-Years
-12%
CAGR 5-Years
0%
CAGR 10-Years
19%
Mettler-Toledo International Inc
NYSE:MTD
Long-Term Debt
$1.9B
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
18%
Agilent Technologies Inc
NYSE:A
Long-Term Debt
$3.3B
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
7%
IQVIA Holdings Inc
NYSE:IQV
Long-Term Debt
$12.3B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
20%
No Stocks Found

Chromadex Corp
Glance View

Market Cap
413.6m USD
Industry
Life Sciences Tools & Services

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

CDXC Intrinsic Value
2.28 USD
Overvaluation 58%
Intrinsic Value
Price

See Also

What is Chromadex Corp's Long-Term Debt?
Long-Term Debt
2k USD

Based on the financial report for Sep 30, 2024, Chromadex Corp's Long-Term Debt amounts to 2k USD.

What is Chromadex Corp's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
-42%

Over the last year, the Long-Term Debt growth was -80%. The average annual Long-Term Debt growth rates for Chromadex Corp have been -42% over the past three years , -51% over the past five years , and -42% over the past ten years .

Back to Top